• info@icbcongress.com
• English
• Persian

• Login

Create Free Account

INTERNATIONAL CONGRESS OF

PharmacoGenetics

• Epigenetics and cancer signaling

• Sogol taher,^1,* Kimiya yarahmadi,² Negar khaki,³
  1. Azad university
  2. Azad university
  3. Azad university and international medical university
  
  
  
• Introduction: Overview of Epigenetics in Cellular Function Epigenetics plays a crucial role in cellular function by regulating gene expression without altering the DNA sequence. This regulation is essential for maintaining cellular homeostasis and facilitating proper responses to environmental changes. For instance, epigenetic mechanisms such as DNA methylation and histone modifications can determine whether specific genes are active or silenced, influencing vital processes like cell differentiation and proliferation. In cancer, these mechanisms can become dysregulated, leading to aberrant gene expression that contributes to tumorigenesis and cancer progression. Breast cancer, in particular, exemplifies this phenomenon, as breast cancer stem cells (BCSCs) exhibit distinct epigenetic changes that impact their behavior in terms of metastasis and resistance to treatments (Hsing-Ju Wu & P. Chu, 2021). Understanding these epigenetic alterations offers potential therapeutic avenues for targeting cancer stem cells and improving treatment outcomes.
• Methods: Mechanisms of Epigenetic Regulation The dysregulation of epigenetic mechanisms can lead to significant alterations in cellular behavior, particularly in cancer. In breast cancer, for example, breast cancer stem cells (BCSCs) show unique epigenetic modifications that influence their ability to metastasize and resist treatment (Hsing-Ju Wu & P. Chu, 2021). This highlights the importance of understanding the balance between epigenetic regulation and gene expression, as these changes do not involve alterations in the DNA sequence itself but can still result in profound effects on cellular functions. Moreover, the role of a-synuclein in neurodegenerative diseases underscores how epigenetic factors can impact gene transcription and contribute to disease progression (A. Surguchov, 2023). By studying these mechanisms, researchers hope to identify novel therapeutic strategies that target the underlying epigenetic changes, potentially improving patient outcomes. Role of Epigenetics in Cancer Development The dysregulation of epigenetic mechanisms can lead to significant alterations in cellular behavior, particularly in cancer. In breast cancer, for example, breast cancer stem cells (BCSCs) show unique epigenetic modifications that influence their ability to metastasize and resist treatment (Hsing-Ju Wu & P. Chu, 2021). This highlights the importance of understanding the balance between epigenetic regulation and gene expression, as these changes do not involve alterations in the DNA sequence itself but can still result in profound effects on cellular functions. Furthermore, various epigenetic abnormalities, such as DNA methylation and histone modifications, are known to play critical roles in breast cancer development and progression (Joanna Szczepanek et al., 2023). By studying these mechanisms, researchers hope to identify novel therapeutic strategies that target the underlying epigenetic changes, potentially improving patient outcomes. Epigenetic Alterations in Tumor Suppressor Genes Understanding the intricate roles of epigenetic alterations, particularly in tumor suppressor genes, is crucial for grasping breast cancer development. These modifications, such as DNA methylation and histone changes, can lead to the silencing of genes responsible for controlling cell growth and division, contributing to uncontrolled proliferation characteristic of tumors (Joanna Szczepanek et al., 2023). Furthermore, breast cancer stem cells (BCSCs) exhibit specific epigenetic changes that not only enhance their ability to metastasize but also confer resistance to conventional treatments (Hsing-Ju Wu & P. Chu, 2021). Targeting these epigenetic mechanisms might provide a novel approach to therapy, allowing for the restoration of normal gene expression and potentially reversing cancer progression. Thus, continued research into the epigenetic landscape of breast cancer may unlock new avenues for effective treatment strategies. Therapeutic Implications of Targeting Epigenetic Modifications in Cancer Moreover, the complexity of breast cancer necessitates a multifaceted approach to therapy that integrates the understanding of epigenetic modifications. Recent studies indicate that combining epigenetic-targeting drugs with established treatments can enhance therapeutic efficacy and overcome resistance associated with BCSCs (Joanna Szczepanek et al., 2023). For instance, agents like azacitidine and vorinostat have shown promising results when used alongside chemotherapy, highlighting their potential in reversing harmful epigenetic changes (Joanna Szczepanek et al., 2023). This approach not only targets the cancer cells directly but also modifies the tumor microenvironment, potentially leading to improved patient outcomes. By harnessing the power of epigenetics in treatment strategies, researchers can aim for more personalized and effective care options for breast cancer patients, paving the way for innovative therapies
• Results: Future Directions in Epigenetics and Cancer Research The integration of epigenetic understanding into cancer therapy represents a significant shift in treatment methodologies. By targeting the specific epigenetic alterations observed in breast cancer, researchers can develop more refined approaches to counteract the disease's complexity. Epigenetic changes, such as DNA methylation and histone modifications, play crucial roles in regulating gene expression and tumor behavior (Hsing-Ju Wu & P. Chu, 2021). The use of epigenetic drugs, including DNA methyltransferase inhibitors and histone deacetylase inhibitors, not only aims to reverse these alterations but also enhances the overall efficacy of traditional therapies (Joanna Szczepanek et al., 2023). This strategic combination could lead to breakthrough treatments that are more effective in managing breast cancer, ultimately improving patient outcomes and personalizing care based on individual epigenetic profiles.
• Conclusion: Future Directions in Epigenetics and Cancer Research The integration of epigenetic understanding into cancer therapy represents a significant shift in treatment methodologies. By targeting the specific epigenetic alterations observed in breast cancer, researchers can develop more refined approaches to counteract the disease's complexity. Epigenetic changes, such as DNA methylation and histone modifications, play crucial roles in regulating gene expression and tumor behavior (Hsing-Ju Wu & P. Chu, 2021). The use of epigenetic drugs, including DNA methyltransferase inhibitors and histone deacetylase inhibitors, not only aims to reverse these alterations but also enhances the overall efficacy of traditional therapies (Joanna Szczepanek et al., 2023). This strategic combination could lead to breakthrough treatments that are more effective in managing breast cancer, ultimately improving patient outcomes and personalizing care based on individual epigenetic profiles.
• Keywords: Cancer signaling Epigenetics Tumor Genes